mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with heme in 1 studies
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (heme) | Trials (heme) | Recent Studies (post-2010) (heme) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 19,086 | 115 | 4,781 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, K; Liang, HL; Mortensen, J; Nilakantan, V; Rajesh, S | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and heme
| Article | Year |
|---|---|
Time-dependant protective effects of mangenese(III) tetrakis (1-methyl-4-pyridyl) porphyrin on mitochondrial function following renal ischemia-reperfusion injury.
Topics: Aconitate Hydratase; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Carrier Proteins; Caspase 3; Cytochromes c; Drug Evaluation, Preclinical; Electron Spin Resonance Spectroscopy; Heme; In Situ Nick-End Labeling; Kidney; Male; Metalloporphyrins; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Time Factors | 2010 |